Emergence Therapeutics
Description: Emergence Therapeutics develops novel antibody-drug conjugates (ADCs) to treat high-need cancers, focusing on Nectin-4 and other targets.
Country: Germany
Based in: Duisburg
Founded: 2019
Funding Stage: Series A/B
Tags: ['Fitness', 'Health Care', 'Wellness']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
